IA
CALA

IFP Advisors’s Calithera Biosciences, Inc CALA Stock Holding History

IFP Advisors’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-10
Closed -$752 – 3211
2019
Q3 		$1K Buy
+10
New +$801 ﹤0.01% 2978
2019
Q1 		– Sell
-10
Closed -$1K – 3671
2018
Q4 		$1K Hold
10
– – ﹤0.01% 3438
2018
Q3 		$1K Hold
10
– – ﹤0.01% 3755
2018
Q2 		$1K Hold
10
– – ﹤0.01% 3807
2018
Q1 		$2K Hold
10
– – ﹤0.01% 3566
2017
Q4 		$2K Hold
10
– – ﹤0.01% 3617
2017
Q3 		$3K Sell
10
-100
-91% -$31.5K ﹤0.01% 3666
2017
Q2 		$33K Buy
+110
New +$29.4K ﹤0.01% 2263

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

IFP Advisors's CALA Position: Q4 2019 in Review

IFP Advisors sold out of Calithera Biosciences, Inc (CALA) in Q4 2019, closing a stake of 10 shares — an estimated $752 sold.

IFP Advisors first reported a position in CALA in Q2 2017 and held it in 8 quarters. The position peaked at $33K in Q2 2017. 82 funds tracked by Wall St. Rank hold CALA as of Q4 2019.

  • IFP Advisors reported no remaining Calithera Biosciences, Inc position as of Q4 2019 after selling out during the quarter.
  • IFP Advisors sold 10 Calithera Biosciences, Inc shares in Q4 2019, an estimated $752.
  • IFP Advisors first reported a position in Calithera Biosciences, Inc in Q2 2017 and held it in 8 quarters.
  • IFP Advisors's Calithera Biosciences, Inc position peaked at $33K in Q2 2017.
  • 82 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2019.

Based on IFP Advisors's 13F filing for Q4 2019, filed 17 Jan 2020.